Inventor

DEAN NICHOLAS M

US50 patents

⚠️ This page may combine multiple inventors who share the name “DEAN NICHOLAS M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DEAN NICHOLAS M

ISIS PHARMACEUTICALS INC

Antisense modulation of novel anti-apoptotic bcl-2-related proteins

Antisense oligonucleotides against JNK

Antisense modulation of BCL-X expression

Antisense modulation of bcl-x expression

Antisense oligonucleotide modulation of multidrug resistance-associated protein

Antisense modulation of bcl-x expression

Antisense modulation of interleukin-5 signal transduction

Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos

Modification of MyD88 splicing using modified oligonucleotides

Antisense oligonucleotide compositions and methods for the modulation of activating protein 1

Antisense inhibition of HPK/GCK-like kinase expression

Antisense oligonucleotide modulation of human thymidylate synthase expression

Antisense oligonucleotide modulation of MDR P-glycoprotein gene expression

Antisense oligonucleotide compositions and methods for the modulation of JNK proteins

Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase C

Antisense inhibition of Fas mediated signaling

Antisense oligonucleotides against human protein kinase C

Antisense oligonucleotides against human protein kinase C

Antisense oligonucleotides against human protein kinase C

Oligonucleotide modulation of protein kinase C

Identification of novel pathways, genes and promoter motifs regulating adipogenesis

Antisense inhibition of transforming growth factor-β expression

Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof

Chimeric oligomeric compounds for modulation of splicing

Oligonucleotide inhibition of protein kinase C

Antisense modulation of daxx expression

Antisense oligonucleotide modulation of human protein kinase C-δ expression

Methoxyethoxy oligonucleotides for modulation of protein kinase C expression

Oligonucleotides for enhanced modulation of protein kinase C expression

Oligonucleotide modulation of protein kinase C

Oligonucleotide inhibition of protein kinase C

Oligonucleotide modulation of protein kinase C

Antisense modulation of Fas mediated signaling

Modulation of c-jun using inhibitors of protein kinase C

Methoxyethoxy oligonucleotides for modulation of protein kinase C expression

Modulation of Tudor-SN expression

Modulation of Aurora B expression

Antisense oligonucleotide inhibition of human serine/threonine protein phosphatase gene expression

DEAN NICHOLAS M

Antisense oligonucleotides directed against connective tissue growth factor and uses thereof

Antisense oligonucleotides directed against connective tissue growth factor and uses thereof

Methods for inhibiting expression of connective tissue growth factor

Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF)

BENNETT C FRANK

Chimeric oligomeric compounds for modulation of splicing

UNIV SOUTH ALABAMA

Antisense oligonucleotides to human serine/threonine protein phosphatase genes

NOVARTIS AG

Combination for treatment of proliferative diseases

ANTISENSE THERAPEUTICS LTD

Modulation of insulin like growth factor I receptor expression

VICKERS TIMOTHY

Modification of MYD88 splicing using modified oligonucleotides

DOBIE KENNETH W

Compositions and their uses directed to HBXIP

EXCALIARD PHARMACEUTICALS INC

Antisense oligonucleotides directed against connective tissue growth factor and uses thereof

MUSTOE THOMAS A

Method for reducing scarring during wound healing using antisense compounds directed to CTGF